Major bleeding risk assessment in atrial fibrillation patients taking vitamin K antagonists
Background. The use of risk scores for the assessment of major bleeding and stroke in patients with atrial fibrillation (AF) helps evaluate the risks and benefits of oral anticoagulation therapy. The aim of this study was to describe the percentage of patients receiving anticoagulants for non-valvu...
Main Authors: | Fernando Pivatto Júnior, André Luís Ferreira da Silva, Indira Valente Bezerra, Leonardo Martins Pires, Luís Carlos Amon, Marina Bergamini Blaya, Rafael Selbach Scheffel |
---|---|
Format: | Article |
Language: | English |
Published: |
Hospital de Clinicas de Porto Alegre ; Universidade Federal do Rio Grande do Sul (UFRGS)
2015-07-01
|
Series: | Clinical and Biomedical Research |
Subjects: | |
Online Access: | http://seer.ufrgs.br/index.php/hcpa/article/view/54273 |
Similar Items
-
Major bleeding risk assessment in atrial fibrillation patients taking vitamin K antagonists
by: Fernando Pivatto Júnior, et al.
Published: (2015-07-01) -
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01) -
Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01) -
Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01) -
Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)